Pharmacy

Ethinyloestradiol Generic Estrace

Home » Prescription Drugs 7 » Ethinyloestradiol Generic Estrace

IndicationsPostmenopausal symptoms due to oestrogen deficiency including prevention of postmenopausal osteoporosis. In women with an intact uterus the addition of a progestogen is essential.Treatment of metastatic breast cancer in postmenopausal women.Treatment of prostatic cancer.Dosage and AdministrationThis will depend on the particular indication used but treatment should be undertaken with as low a dose as possible and for as short a period as is necessary.Menopausal symptoms: 0.01-0.05mg daily.Osteoporosis: 0.02-0.05mg daily.Prostatic and mammary carcinoma: 1-2mg daily.

Buy Ethinyloestradiol Generic Estrace and other Prescription Drugs 7 products online at Medstore.

Buy Online at Medstore - Click Here!

About Ethinyloestradiol Generic Estrace:

Product Type: Prescription Drugs 7

Ethinyloestradiol ( Generic Estrace Femtrace Gynodiol )

Ethinyloestradiol (Generic Estrace Femtrace Gynodiol)

Generic Estrace Femtrace Gynodiol

10mcg 100 Tablets 200(2 x 100) Tablets Generic Estrace Femtrace Gynodiol Ethinyloestradiol

View more Prescription Drugs 7

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.